Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 23 h ago

DNA X, Inc.: LYTTON LAURENCE W amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Lytton Laurence W filed an amended Schedule 13G with the SEC (accession 0000935836-26-000618) updating his beneficial ownership stake in DNA X, Inc. The filing, made under the short-form passive-investor regime, revises his previously reported position in the company. The amendment signals a change in his holdings, though the headline disclosure did not specify the revised share count or percentage. Investors should watch for the full filing details to gauge whether the adjustment reflects accumulation or reduction, and monitor any further 13G or 13D activity for signs of shifting conviction.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

DNA X, Inc., Lytton Laurence W